These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 9041336)
1. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. Noah TL; Black HR; Cheng PW; Wood RE; Leigh MW J Infect Dis; 1997 Mar; 175(3):638-47. PubMed ID: 9041336 [TBL] [Abstract][Full Text] [Related]
2. Elemental content of airway surface liquid from infants with cystic fibrosis. Hull J; Skinner W; Robertson C; Phelan P Am J Respir Crit Care Med; 1998 Jan; 157(1):10-4. PubMed ID: 9445271 [TBL] [Abstract][Full Text] [Related]
3. Nasal wash as an alternative to bronchoalveolar lavage in detecting early pulmonary inflammation in children with cystic fibrosis. Pitrez PM; Brennan S; Turner S; Sly PD Respirology; 2005 Mar; 10(2):177-82. PubMed ID: 15823182 [TBL] [Abstract][Full Text] [Related]
5. Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis. Kirchner KK; Wagener JS; Khan TZ; Copenhaver SC; Accurso FJ Am J Respir Crit Care Med; 1996 Nov; 154(5):1426-9. PubMed ID: 8912759 [TBL] [Abstract][Full Text] [Related]
6. Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases. Hentschel J; Müller U; Doht F; Fischer N; Böer K; Sonnemann J; Hipler C; Hünniger K; Kurzai O; Markert UR; Mainz JG J Immunol Methods; 2014 Feb; 404():41-51. PubMed ID: 24370751 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment. Hentschel J; Jäger M; Beiersdorf N; Fischer N; Doht F; Michl RK; Lehmann T; Markert UR; Böer K; Keller PM; Pletz MW; Mainz JG BMC Pulm Med; 2014 May; 14():82. PubMed ID: 24885494 [TBL] [Abstract][Full Text] [Related]
8. Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients. McMorran BJ; Patat SA; Carlin JB; Grimwood K; Jones A; Armstrong DS; Galati JC; Cooper PJ; Byrnes CA; Francis PW; Robertson CF; Hume DA; Borchers CH; Wainwright CE; Wainwright BJ Clin Chem; 2007 Oct; 53(10):1782-91. PubMed ID: 17702859 [TBL] [Abstract][Full Text] [Related]
9. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Muhlebach MS; Noah TL Am J Respir Crit Care Med; 2002 Apr; 165(7):911-5. PubMed ID: 11934713 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of IL-6 and soluble IL-6 receptor by neutrophil derived serine proteases in cystic fibrosis. McGreal EP; Davies PL; Powell W; Rose-John S; Spiller OB; Doull I; Jones SA; Kotecha S Biochim Biophys Acta; 2010; 1802(7-8):649-58. PubMed ID: 20438838 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Dean TP; Dai Y; Shute JK; Church MK; Warner JO Pediatr Res; 1993 Aug; 34(2):159-61. PubMed ID: 8233718 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Muhlebach MS; Stewart PW; Leigh MW; Noah TL Am J Respir Crit Care Med; 1999 Jul; 160(1):186-91. PubMed ID: 10390398 [TBL] [Abstract][Full Text] [Related]
14. Cytokines in nasal lavages and plasma and their correlation with clinical parameters in cystic fibrosis. Paats MS; Bergen IM; Bakker M; Hoek RA; Nietzman-Lammering KJ; Hoogsteden HC; Hendriks RW; van der Eerden MM J Cyst Fibros; 2013 Dec; 12(6):623-9. PubMed ID: 23751406 [TBL] [Abstract][Full Text] [Related]
15. The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10. Dosanjh AK; Elashoff D; Robbins RC J Interferon Cytokine Res; 1998 Oct; 18(10):851-4. PubMed ID: 9809620 [TBL] [Abstract][Full Text] [Related]
16. BALF nitrite as an indicator of inflammation in children with cystic fibrosis. Cetin I; Ozçelik U; Goçmen A; Kiper N; Doğru D; Yalçin E Respiration; 2004; 71(6):625-9. PubMed ID: 15627874 [TBL] [Abstract][Full Text] [Related]
17. Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis. Peterson-Carmichael SL; Harris WT; Goel R; Noah TL; Johnson R; Leigh MW; Davis SD Pediatr Pulmonol; 2009 May; 44(5):503-11. PubMed ID: 19382221 [TBL] [Abstract][Full Text] [Related]
18. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. Sagel SD; Gibson RL; Emerson J; McNamara S; Burns JL; Wagener JS; Ramsey BW; ; J Pediatr; 2009 Feb; 154(2):183-8. PubMed ID: 18822427 [TBL] [Abstract][Full Text] [Related]
19. IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbations. Solomon GM; Frederick C; Zhang S; Gaggar A; Harris T; Woodworth BA; Steele C; Rowe SM PLoS One; 2013; 8(8):e72398. PubMed ID: 23977293 [TBL] [Abstract][Full Text] [Related]
20. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Wilmott RW; Kassab JT; Kilian PL; Benjamin WR; Douglas SD; Wood RE Am Rev Respir Dis; 1990 Aug; 142(2):365-8. PubMed ID: 2382901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]